This research was conducted to examine the expression of claudin-6, occludin and MMP-2 in 36 ovarian papillary serous carcinomas and 26 ovarian serous adenomas specimens, and investigate the relationship between their expression and clinical properties of the ovarian tumor patients. This evidence concerns the gene OCLN and ovarian neoplasm.